Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT DILTIAZEM CD 300MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2023-04-28 61340
ACT ENALAPRIL 8MG TABLET Resolved 2018-09-12 2019-03-12 61343
ACT ENALAPRIL 2MG TABLET Resolved 2018-09-12 2019-01-31 61346
ACT ENALAPRIL 16MG TABLET Resolved 2018-09-12 2019-08-06 61349
ACT ENALAPRIL 4MG TABLET Resolved 2018-09-12 2019-01-31 61352
TEVA-OLMESARTAN / HCTZ 12.5MG 40MG TABLET Resolved 2018-09-12 2020-06-11 61359
CARBOPLATIN INJECTION 10MG LIQUID Resolved 2018-09-12 2018-10-11 61362
ACT CIPROFLOXACIN 750MG TABLET Resolved 2018-09-12 2018-10-11 61365
ETOPOSIDE INJECTION 20MG LIQUID Resolved 2018-09-12 2020-03-16 61368
TEVA-LEVETIRACETAM 250MG TABLET Resolved 2018-09-27 2018-10-12 62458
TEVA-TAMOXIFEN 20MG TABLET Resolved 2018-10-11 2019-04-27 63757
TEVA-OLMESARTAN 40MG TABLET Resolved 2018-10-22 2020-06-11 65340
TEVA-OLMESARTAN / HCTZ 12.5MG 20MG TABLET Resolved 2018-10-22 2020-06-11 65343
TEVA-OLMESARTAN / HCTZ 25MG 40MG TABLET Resolved 2018-10-22 2020-06-11 65346
TEVA-OLMESARTAN 20MG TABLET Resolved 2018-10-22 2020-06-11 65350
TEVA-PRAZOSIN 5MG TABLET Resolved 2018-10-23 2019-04-27 65494
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65990
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65996
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999

Showing 541 to 560 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-DILTIAZEM CD 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81307
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
TEVA-PAROXETINE 10MG TABLET Discontinued 2019-04-11 2019-04-11 81313
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-NAPROXEN SODIUM DS 550MG TABLET Discontinued 2019-04-11 2019-04-11 81350
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353
TEVA-LENOLTEC NO. 1 300MG 8MG 15MG TABLET Discontinued 2019-04-11 2019-04-11 81362
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368
TEVA-FAMOTIDINE 20MG TABLET Discontinued 2019-04-11 2019-04-11 81371
TEVA-PREDNISONE 5MG TABLET Discontinued 2019-04-11 2019-04-11 81376
ACT DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81381
TEVA-LAMOTRIGINE 25MG TABLET Discontinued 2019-04-11 2019-04-11 81388
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393

Showing 101 to 120 of 250